Skip to main content
Log in

The Nonsynonymous Thr105Ile Polymorphism of the Histamine N-Methyltransferase is Associated to the Risk of Developing Essential Tremor

  • Original Paper
  • Published:
NeuroMolecular Medicine Aims and scope Submit manuscript

Abstract

Objective We analyzed in patients with essential tremor (ET) the Thr105Ile polymorphism of the Histamine N-methyltransferase (HNMT) enzyme that is associated to Parkinson’s disease (PD) risk. Methods Leukocytary DNA from 204 ET patients and a control group of 295 unrelated healthy individuals was studied for the nonsynonymous HNMT Thr105Ile polymorphism by using amplification-restriction analyses. Results Patients with ET showed a higher frequency of homozygous HNMT 105Thr genotypes leading to high metabolic activity (p < 0.015) with a statistically significant gene-dose effect, as compared to healthy subjects. These findings were independent of gender, and of tremor localization, but the association of the HNMT polymorphism is more prominent among patients with late-onset ET (p < 0.007). Conclusion These results, combined with previous findings indicating alterations in the frequency for the HNMT Thr105Ile polymorphism in patients with PD, suggest that alterations of histamine homeostasis in the SNC are associated with the risk of movement disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agundez, J. A., Jimenez-Jimenez, F. J., Tejeda, R., Ledesma, M. C., Orti-Pareja, M., Gasalla, T., et al. (1997). CYP2D6 polymorphism is not associated with essential tremor. European Neurology, 38, 99–104.

    Article  PubMed  CAS  Google Scholar 

  • Agundez, J. A., Luengo, A., Herraez, O., Martinez, C., Alonso-Navarro, H., Jimenez-Jimenez, F. J., et al. (2007) Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson’s disease. Neuromolecular Medicine, 10(1), 10–16.

    Article  PubMed  CAS  Google Scholar 

  • Alonso-Navarro, H., Martinez, C., Garcia-Martin, E., Benito-Leon, J., Garcia-Ferrer, I., Vazquez-Torres, P., et al. (2006). CYP2C19 polymorphism and risk for essential tremor. European Neurology, 56, 119–123.

    Article  PubMed  CAS  Google Scholar 

  • Anichtchik, O. V., Rinne, J. O., Kalimo, H., & Panula, P. (2000). An altered histaminergic innervation of the substantia nigra in Parkinson’s disease. Experimental Neurology, 163, 20–30.

    Article  PubMed  CAS  Google Scholar 

  • Benito-Leon, J., Bermejo-Pareja, F., & Louis, E. D. (2005). Incidence of essential tremor in three elderly populations of central Spain. Neurology, 64, 1721–1725.

    Article  PubMed  Google Scholar 

  • Benito-Leon, J., & Louis, E. D. (2007). Clinical update: Diagnosis and treatment of essential tremor. Lancet, 369, 1152–1154.

    Article  PubMed  Google Scholar 

  • Brennan, P. (2002). Gene-environment interaction and aetiology of cancer: What does it mean and how can we measure it? Carcinogenesis, 23, 381–387.

    Article  PubMed  CAS  Google Scholar 

  • Busenbark, K. L., Huber, S. J., Greer, G., Pahwa, R., & Koller, W. C. (1992). Olfactory function in essential tremor. Neurology, 42, 1631–1632.

    PubMed  CAS  Google Scholar 

  • Coelho, M. H., Silva, I. J., Azevedo, M. S., & Manso, C. F. (1991). Decrease in blood histamine in drug-treated parkinsonian patients. Molecular and Chemical Neuropathology, 14, 77–85.

    Article  PubMed  CAS  Google Scholar 

  • Daly, A. K., & Day, C. P. (2001). Candidate gene case-control association studies: Advantages and potential pitfalls. British Journal of Clinical Pharmacology, 52, 489–499.

    Article  PubMed  CAS  Google Scholar 

  • Deuschl, G., Bain, P., & Brin, M. (1998). Consensus statement of the movement disorder society on tremor. Ad Hoc Scientific Committee. Movement Disorders, 13(Suppl. 3), 2–23.

    PubMed  Google Scholar 

  • Dogu, O., Sevim, S., Camdeviren, H., Sasmaz, T., Bugdayci, R., Aral, M., et al. (2003). Prevalence of essential tremor: Door-to-door neurologic exams in Mersin Province, Turkey. Neurology, 61, 1804–1806.

    PubMed  CAS  Google Scholar 

  • Findley, L. J. (2000). Epidemiology and genetics of essential tremor. Neurology, 54, S8–S13.

    PubMed  CAS  Google Scholar 

  • Garcia-Martin, E., Garcia-Menaya, J., Sanchez, B., Martinez, C., Rosendo, R., & Agundez, J. A. (2007). Polymorphisms of histamine-metabolizing enzymes and clinical manifestations of asthma and allergic rhinitis. Clinical and Experimental Allergy, 37, 1175–1182.

    Article  PubMed  CAS  Google Scholar 

  • Gulcher, J. R., Jonsson, P., Kong, A., Kristjansson, K., Frigge, M. L., Karason, A., et al. (1997). Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nature Genetics, 17, 84–87.

    Article  PubMed  CAS  Google Scholar 

  • Higgins, J. J., Jankovic, J., Lombardi, R. Q., Pucilowska, J., Tan, E. K., Ashizawa, T., et al. (2003). Haplotype analysis of the ETM2 locus in familial essential tremor. Neurogenetics, 4, 185–189.

    Article  PubMed  CAS  Google Scholar 

  • Higgins, J. J., Lombardi, R. Q., Pucilowska, J., Jankovic, J., Tan, E. K., & Rooney, J. P. (2005). A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology, 64, 417–421.

    PubMed  CAS  Google Scholar 

  • Higgins, J. J., Loveless, J. M., Jankovic, J., & Patel, P. I. (1998). Evidence that a gene for essential tremor maps to chromosome 2p in four families. Movement Disorders, 13, 972–977.

    Article  PubMed  CAS  Google Scholar 

  • Illarioshkin, S. N., Rakhmonov, R. A., Ivanova-Smolenskaia, I. A., Brice, A., Markova, E. D., Miklina, N. I., et al. (2002). Molecular genetic analysis of essential tremor. Genetika, 38, 1704–1709.

    PubMed  CAS  Google Scholar 

  • Jimenez-Jimenez, F. J., de Toledo-Heras, M., Alonso-Navarro, H., Ayuso-Peralta, L., Arevalo-Serrano, J., Ballesteros-Barranco, A., et al. (2007). Environmental risk factors for essential tremor. European Neurology, 58, 106–113.

    PubMed  Google Scholar 

  • Josephs, K. A., Matsumoto, J. Y., & Ahlskog, J. E. (2006). Benign tremulous parkinsonism. Archives of Neurology, 63, 354–357.

    Article  PubMed  Google Scholar 

  • Khan, N. L., Jain, S., Lynch, J. M., Pavese, N., Abou-Sleiman, P., Holton, J. L., et al. (2005). Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson’s disease: Clinical, pathological, olfactory and functional imaging and genetic data. Brain, 128, 2786–2796.

    Article  PubMed  Google Scholar 

  • Kim, S. H., Krapfenbauer, K., Cheon, M. S., Fountoulakis, M., Cairns, N. J., & Lubec, G. (2002). Human brain cytosolic histamine-N-methyltransferase is decreased in Down syndrome and increased in Pick’s disease. Neuroscience Letters, 321, 169–172.

    Article  PubMed  CAS  Google Scholar 

  • Koller, W. C., Busenbark, K., & Miner, K. (1994). The relationship of essential tremor to other movement disorders: Report on 678 patients. Essential Tremor Study Group. Annals of Neurology, 35, 717–723.

    Article  PubMed  CAS  Google Scholar 

  • Langlais, P. J., Zhang, S. X., Weilersbacher, G., Hough, L. B., & Barke, K. E. (1994). Histamine-mediated neuronal death in a rat model of Wernicke’s encephalopathy. Journal of Neuroscience Research, 38, 565–574.

    Article  PubMed  CAS  Google Scholar 

  • Louis, E. D. (2005). Essential tremor. Lancet Neurology, 4, 100–110.

    Article  PubMed  Google Scholar 

  • Louis, E. D., Honig, L. S., Vonsattel, J. P., Maraganore, D. M., Borden, S., & Moskowitz, C. B. (2005). Essential tremor associated with focal nonnigral Lewy bodies: A clinicopathologic study. Archives of Neurology, 62, 1004–1007.

    Article  PubMed  Google Scholar 

  • Louis, E. D., & Jurewicz, E. C. (2003). Olfaction in essential tremor patients with and without isolated rest tremor. Movement Disorders, 18, 1387–1389.

    Article  PubMed  Google Scholar 

  • Louis, E. D., Marder, K., Cote, L., Wilder, D., Tang, M. X., Lantigua, R., et al. (1996). Prevalence of a history of shaking in persons 65 years of age and older: Diagnostic and functional correlates. Movement Disorders, 11, 63–69.

    Article  PubMed  CAS  Google Scholar 

  • Martinez, C., Garcia-Martin, E., Alonso-Navarro, H., Jimenez-Jimenez, F. J., Benito-Leon, J., Garcia-Ferrer, I., et al. (2007). Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor. Neuromolecular Medicine, 9, 195–204.

    Article  PubMed  CAS  Google Scholar 

  • Mjones, H. (1949). Paralysis agitans: A clinical genetic study. Acta Psychiatrica et Neurologica Scandinavica, 54, 1–195.

    Google Scholar 

  • Ondo, W. G., & Lai, D. (2005). Olfaction testing in patients with tremor-dominant Parkinson’s disease: Is this a distinct condition? Movement Disorders, 20, 471–475.

    Article  PubMed  Google Scholar 

  • O’Suilleabhain, P. E. (2006). Parkinson disease with severe tremor but otherwise mild deterioration. Archives of Neurology, 63, 321–322.

    Article  PubMed  Google Scholar 

  • Pigullo, S., Di Maria, E., Marchese, R., Bellone, E., Gulli, R., Scaglione, C., et al. (2003). Essential tremor is not associated with alpha-synuclein gene haplotypes. Movement Disorders, 18, 823–826.

    Article  PubMed  Google Scholar 

  • Prell, G. D., & Green, J. P. (1991). Histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid. Agents and Actions. Supplements, 33, 343–363.

    PubMed  CAS  Google Scholar 

  • Preuss, C. V., Wood, T. C., Szumlanski, C. L., Raftogianis, R. B., Otterness, D. M., Girard, B., et al. (1998). Human histamine N-methyltransferase pharmacogenetics: Common genetic polymorphisms that alter activity. Molecular Pharmacology, 53, 708–717.

    PubMed  CAS  Google Scholar 

  • Rajput, A. H., Rozdilsky, B., Ang, L., & Rajput, A. (1993). Significance of parkinsonian manifestations in essential tremor. Canadian Journal of Neurological Sciences, 20, 114–117.

    PubMed  CAS  Google Scholar 

  • Shahed, J., & Jankovic, J. (2007). Exploring the relationship between essential tremor and Parkinson’s disease. Parkinsonism & Related Disorders, 13, 67–76.

    Article  Google Scholar 

  • Skipper, L., Shen, H., Chua, E., Bonnard, C., Kolatkar, P., Tan, L. C., et al. (2005). Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology, 65, 1319–1321.

    Article  PubMed  CAS  Google Scholar 

  • Tan, E. K., Matsuura, T., Nagamitsu, S., Khajavi, M., Jankovic, J., & Ashizawa, T. (2000). Polymorphism of NACP-Rep1 in Parkinson’s disease: An etiologic link with essential tremor? Neurology., 54, 1195–1198.

    PubMed  CAS  Google Scholar 

  • Thoburn, K. K., Hough, L. B., Nalwalk, J. W., & Mischler, S. A. (1994). Histamine-induced modulation of nociceptive responses. Pain, 58, 29–37.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are thankful to Ms. Diana Herrero for technical assistance and to Prof. James McCue for assistance in language editing. This work was supported in part by Grants SAF 2003-00967 from Ministerio de Ciencia y Tecnología, FIS 05/1056, 06/1252 and RETICS 07/0064/0016 from Fondo de Investigación Sanitaria, Instituto de Salud Carlos III.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elena García-Martín.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ledesma, M.C., García-Martín, E., Alonso-Navarro, H. et al. The Nonsynonymous Thr105Ile Polymorphism of the Histamine N-Methyltransferase is Associated to the Risk of Developing Essential Tremor. Neuromol Med 10, 356–361 (2008). https://doi.org/10.1007/s12017-008-8040-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12017-008-8040-3

Keywords

Navigation